Company intelligence / Profile preview
Pandorum Technologies
Bengaluru, Karnataka, Indiapandorum.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Pandorum Technologies develops proprietary regenerative medicine platforms focused on creating functional human tissues such as bioengineered corneas and livers. The company also works on cell-free exosome-based therapies targeting post-trauma lung repair. Most programs are at preclinical or early translational stages with no reported late-stage clinical results yet.
- Therapeutic areas
- GastroenterologyPulmonologyOphthalmology
- Modalities
- Stem cell-derived exosomes (cell-free therapies)Mesenchymal stem cells (MSC)Bioengineered tissues/organoids (cornea, liver)Biomaterials for tissue engineering3D bioprinting and self assembly of tissues
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Pandorum Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pandorum Technologies.